University of Pennsylvania/Scheie Eye Institute
Philadelphia, Pennsylvania 19104
1 studies enrolling now · 18 studies all time
What they study most
Cornea, Corneal Defect, Corneal Ulcer, Deaf Blind, Diabetes, Diabetic Macular Edema, Diabetic Retinopathy, Dry Eye, Eye Diseases, Hereditary, Eye Disorders Congenital, Inherited Retinal Degeneration, Mesenchymal Stromal Cells
Studies at this site
- Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants — Recruiting now
- Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells — Recruiting now
- Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene — Running, not enrolling
- Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells — Completed
- Anti-VEGF Treatment for Prevention of PDR/DME — Completed
- A Trial of Neuroprotection With ACTH in Acute Optic Neuritis — Stopped early
- Argus® II Retinal Stimulation System Feasibility Protocol — Completed
- Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
- Treatment for CI-DME in Eyes With Very Good VA Study — Completed
- Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) — Stopped early
- Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome — Completed
- Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema — Completed
- Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control — Completed
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed
- Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy — Completed
- Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
- Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity — Stopped early